PURPOSE: Vitamins A, C, and E and folate have anticarcinogenic properties and thus might protect against cancer. Few known modifiable risk factors for ovarian cancer exist. We examined the associations between dietary and total (food and supplemental) vitamin intake and the risk of invasive epithelial ovarian cancer. METHODS: The primary data from 10 prospective cohort studies in North America and Europe were analyzed. Vitamin intakes were estimated from validated food frequency questionnaires in each study. Study-specific relative risks (RRs) were estimated using the Cox proportional hazards model and then combined using a random-effects model. RESULTS: Among 501,857 women, 1,973 cases of ovarian cancer occurred over a median follow-up period of 7-16 years across studies. Dietary and total intakes of each vitamin were not significantly associated with ovarian cancer risk. The pooled multivariate RRs [95% confidence intervals (CIs)] for incremental increases in total intake of each vitamin were 1.02 (0.97-1.07) for vitamin A (increment: 1,300 mcg/day), 1.01 (0.99-1.04) for vitamin C (400 mg/day), 1.02 (0.97-1.06) for vitamin E (130 mg/day), and 1.01 (0.96-1.07) for folate (250 mcg/day). Multivitamin use (vs. nonuse) was not associated with ovarian cancer risk (pooled multivariate RR = 1.00, 95% CI 0.89-1.12). Associations did not vary substantially by study, or by subgroups of the population. Greater vitamin intakes were associated with modestly higher risks of endometrioid tumors (n = 156 cases), but not with other histological types. CONCLUSION: These results suggest that consumption of vitamins A, C, and E and folate during adulthood does not play a major role in ovarian cancer risk.
PURPOSE: Vitamins A, C, and E and folate have anticarcinogenic properties and thus might protect against cancer. Few known modifiable risk factors for ovarian cancer exist. We examined the associations between dietary and total (food and supplemental) vitamin intake and the risk of invasive epithelial ovarian cancer. METHODS: The primary data from 10 prospective cohort studies in North America and Europe were analyzed. Vitamin intakes were estimated from validated food frequency questionnaires in each study. Study-specific relative risks (RRs) were estimated using the Cox proportional hazards model and then combined using a random-effects model. RESULTS: Among 501,857 women, 1,973 cases of ovarian cancer occurred over a median follow-up period of 7-16 years across studies. Dietary and total intakes of each vitamin were not significantly associated with ovarian cancer risk. The pooled multivariate RRs [95% confidence intervals (CIs)] for incremental increases in total intake of each vitamin were 1.02 (0.97-1.07) for vitamin A (increment: 1,300 mcg/day), 1.01 (0.99-1.04) for vitamin C (400 mg/day), 1.02 (0.97-1.06) for vitamin E (130 mg/day), and 1.01 (0.96-1.07) for folate (250 mcg/day). Multivitamin use (vs. nonuse) was not associated with ovarian cancer risk (pooled multivariate RR = 1.00, 95% CI 0.89-1.12). Associations did not vary substantially by study, or by subgroups of the population. Greater vitamin intakes were associated with modestly higher risks of endometrioid tumors (n = 156 cases), but not with other histological types. CONCLUSION: These results suggest that consumption of vitamins A, C, and E and folate during adulthood does not play a major role in ovarian cancer risk.
Authors: Anita Koushik; David J Hunter; Donna Spiegelman; Kristin E Anderson; Alan A Arslan; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; James R Cerhan; Graham A Colditz; Gary E Fraser; Jo L Freudenheim; Jeanine M Genkinger; R Alexandra Goldbohm; Susan E Hankinson; Karen L Koenig; Susanna C Larsson; Michael Leitzmann; Marjorie L McCullough; Anthony B Miller; Alpa Patel; Thomas E Rohan; Arthur Schatzkin; Ellen Smit; Walter C Willett; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-09 Impact factor: 4.254
Authors: E Bidoli; C La Vecchia; R Talamini; E Negri; M Parpinel; E Conti; M Montella; M A Carbone; S Franceschi Journal: Ann Oncol Date: 2001-11 Impact factor: 32.976
Authors: Stephanie A Navarro Silvera; Meera Jain; Geoffrey R Howe; Anthony B Miller; Thomas E Rohan Journal: Eur J Cancer Prev Date: 2006-12 Impact factor: 2.497
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Jeanine M Genkinger; David J Hunter; Donna Spiegelman; Kristin E Anderson; Alan Arslan; W Lawrence Beeson; Julie E Buring; Gary E Fraser; Jo L Freudenheim; R Alexandra Goldbohm; Susan E Hankinson; David R Jacobs; Anita Koushik; James V Lacey; Susanna C Larsson; Michael Leitzmann; Marji L McCullough; Anthony B Miller; Carmen Rodriguez; Thomas E Rohan; Leo J Schouten; Roy Shore; Ellen Smit; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-02 Impact factor: 4.254
Authors: Marian L Neuhouser; Sylvia Wassertheil-Smoller; Cynthia Thomson; Aaron Aragaki; Garnet L Anderson; JoAnn E Manson; Ruth E Patterson; Thomas E Rohan; Linda van Horn; James M Shikany; Asha Thomas; Andrea LaCroix; Ross L Prentice Journal: Arch Intern Med Date: 2009-02-09
Authors: Lindsay M Hannan; Michael F Leitzmann; James V Lacey; Lisa H Colbert; Demetrius Albanes; Arthur Schatzkin; Catherine Schairer Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-05 Impact factor: 4.254
Authors: Mary C Playdon; Christina M Nagle; Torukiri I Ibiebele; Leah M Ferrucci; Melinda M Protani; Jonathan Carter; Simon E Hyde; Deborah Neesham; James L Nicklin; Susan T Mayne; Penelope M Webb Journal: Br J Cancer Date: 2017-05-02 Impact factor: 7.640
Authors: Junyi Xin; Xia Jiang; Shuai Ben; Qianyu Yuan; Li Su; Zhengdong Zhang; David C Christiani; Mulong Du; Meilin Wang Journal: BMC Med Date: 2022-05-11 Impact factor: 11.150